| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0078 | 1 |